AGT and hypertensive disorder: Increased mineralocorticoid receptor leads to enhanced AT1 and glutamate receptor-dependent signaling in the PVN, thereby promoting a chronic increase in circulating Ang II to maintain BP in Ang II-dependent hypertension (77).